(Q34648517)

3 August 2017

Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteers (English)

1 reference

3 August 2017

1 reference

Angela Sansone-Parsons

1

object named as

Angela Sansone-Parsons

0 references

author name string

Angela Sansone-Parsons

1

1 reference

3 August 2017

Gopal Krishna

2

1 reference

3 August 2017

Angela Calzetta

3

1 reference

3 August 2017

David Wexler

4

1 reference

3 August 2017

Bhavna Kantesaria

5

1 reference

3 August 2017

Mitchell A Rosenberg

6

1 reference

3 August 2017

Marc A Saltzman

7

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

Antimicrobial Agents and Chemotherapy

3 August 2017

1 reference

3 August 2017

50

1 reference

3 August 2017

5

1 reference

3 August 2017

1881-1883

1 reference

Disposition of posaconazole following single-dose oral administration in healthy subjects

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472190

Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472190

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472190

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472190

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472190

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472190

Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472190

Refractory coccidioidomycosis treated with posaconazole

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472190

Posaconazole pharmacokinetics, safety, and tolerability in subjects with varying degrees of chronic renal disease

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472190

Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472190

In vitro susceptibilities of zygomycetes to conventional and new antifungals

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472190

10.1128/AAC.50.5.1881-1883.2006

26 October 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference